Investor relations
Human-centred systems for learning and rehabilitation
NeuraXplore is building AI, XR, and neuroscience-informed systems for adaptive learning and neurorehabilitation, with European privacy-by-design and human-in-the-loop choices as structural advantages.
Investment thesis
Measurement, adaptation, and oversight in one loop
Instruction and therapy still assume a narrow band of attention and working memory. NeuraXplore measures unobtrusive, task-linked proxies for cognitive load at the edge, adapts scaffolding in real time where appropriate, and keeps teachers and clinicians in control. That closed loop applies across education (NeuroPALS and PALS Cortex), career orientation (PALS Pathway), and clinical neurorehabilitation concepts (MindForge), with shared technology and differentiated go-to-market.
Market context
Europe's e-learning market is around €111B (2025) and the EdTech sector is estimated near €54B (2024). Against that backdrop, the figures below are a bottom-up, priced estimate for our specific segment — directional sector scale, not a revenue forecast.
- TAM
- ≈ €2.8B / yr
- SAM
- ≈ €70M / yr
- SOM
- ≈ €2–3M ARR
EU secondary education, at our price
≈37.5M lower- and upper-secondary pupils in the EU (Eurostat, 2024) × €75 per student per year.
Netherlands secondary beachhead
≈930k Dutch secondary (vo) students (DUO/OCW, 2024) × €75 per student per year.
Near-term obtainable
A low single-digit share (~3–5%) of Dutch secondary students across the scale-up phase.
Estimates only, built on our illustrative €75/student/year structure and public enrolment data. Actual pricing, cohort sizes, and adoption will differ.
Health and neurorehabilitation
≈ €60B / yr
EU stroke-care burden (2017, SAFE), with ~1.1M strokes in Europe each year and ~10M people living with the long-term effects.
MindForge addresses an emerging slice of this need: neurorehabilitation devices are a ~$2B global market growing at double-digit rates, with VR-supported rehabilitation a fast-growing segment. The demand is for systems that improve engagement and preparation for therapy, without replacing clinical judgment.
Commercial model
Institutional contracts with optional consumer reach
B2B institutions
Per-school or per-institution agreements. Illustrative structure discussed with early adopters: on the order of €75 per student per year for licensed deployment, subject to scope, cohort size, and services.
Recurring, contract-led revenue
B2C
Consumer subscription for out-of-school use, discussed at approximately €15 per month where product economics and local pricing support it.
Diversification and direct feedback loop
Traction
Early pilot work and research depth
- Early pilot: Novo College (NeuroPALS pilot with educator oversight).
- Pipeline: Additional school conversations and clinical design partners in Europe.
- Research network: Dia, LVO Limburgs Voortgezet Onderwijs, Novo College, and Brightlands Maastricht Health Campus.
- Non-dilutive support: MIT feasibility funding received (timing and use per internal records).
Validation partners
Education network partnership for neuro-adaptive learning rollout
Regional secondary education network and validation context
Early NeuroPALS pilot with educator oversight
Innovation ecosystem for health and life sciences
IP and defensibility
Hybrid approach: trade secrets around signal handling and adaptation, copyright on platform assets and materials, and patent landscaping informed by RVO (Netherlands Enterprise Agency) search advice. We do not claim freedom-to-operate until counsel completes FTO work for each product line and jurisdiction.
- Edge-first processing and adaptation pipelines
- Platform, content, and documentation under copyright
- Patent strategy staged with product milestones and counsel review
Leadership
Founder-led product and partnerships
Ramon Frissen
CEO and founder
Background in software and international education. Leads product vision and institutional partnerships.
Roadmap
Scale with evidence and channel readiness
H2 2026
Scale-up
More Dutch schools and first structured clinical pilots for MindForge.
2027
EU expansion
Localized offers where regulatory and channel readiness align.
2028
Ecosystem
Interoperability with major education and health IT where customers require it.
Investor access
Request the deck or diligence conversation
We share investor materials and diligence context on request. Use the channels below for deck access, secure data-room conversations, or a meeting with leadership.